PIPERACILLIN/TAZOBACTAM KABI 4g/0.5G powder infusion solution medication leaflet

J01CR05 • piperacillin + tazobactam • Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors

The combination of piperacillin and tazobactam is an antibiotic used for the treatment of severe bacterial infections, including intra-abdominal infections, skin and soft tissue infections, and nosocomial pneumonia. Piperacillin works by inhibiting bacterial cell wall synthesis, while tazobactam inhibits beta-lactamases, enhancing piperacillin's efficacy.

The medication is administered intravenously, as directed by a doctor, usually three to four times daily. It is important for patients to follow the treatment regimen and complete the full course of antibiotics.

Patients should be aware of potential side effects, such as diarrhea, nausea, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include diarrhea, nausea, and skin rashes. In rare cases, severe reactions such as pseudomembranous colitis or anaphylactic reactions may occur. Patients should be informed of these risks before use.